Cardiac resynchronization therapy and its potential proarrhythmic effect.
Cardiac resynchronization therapy (CRT) has become an established adjunctive treatment to optimal pharmacologic therapy in patients with advanced chronic heart failure (CHF), diminished left ventricular (LV) function and intraventricular conduction delay. Although CRT has been shown to improve ventricular hemodynamics, quality of life and exercise capacity, there is some evidence that it may rarely potentiate ventricular arrhythmias. As CRT is considered for an expanded population of CHF patients, and left-sided pacing is considered as an option for pacemaker-indicated patients (potentially without defibrillator backup), the effect of these pacing modalities on the incidence of ventricular tachyarrhythmia must be systematically studied and mechanistically understood. Strategies to prospectively predict the proarrhythmic potential of LV epicardial pacing need to be developed, and therapy accordingly individualized. This review attempts to summarize the current information on proarrhythmia in resynchronization therapy.
Basu Ray
Indranill
I
Harvard Thorndike Electrophysiology Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Guidant Corporation, St. Paul, Minnesota, USA.
Fendelander
Lahn
L
Singh
Jagmeet P
JP
D002304:Cardiac Pacing, Artificial / Q000009:adverse effects* / Q000401:mortality; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D017147:Defibrillators, Implantable; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D012307:Risk Factors; D017180:Tachycardia, Ventricular / Q000209:etiology* / Q000401:mortality; D018487:Ventricular Dysfunction, Left / Q000628:therapy*